| 0 (0%) | 01-19 18:54 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 9.11 |
1-year : | 10.24 |
| Resists | First : | 7.79 |
Second : | 8.77 |
| Pivot price | 6.88  |
|||
| Supports | First : | 6.23 |
Second : | 5.18 |
| MAs | MA(5) : | 7.44 |
MA(20) : | 6.83 |
| MA(100) : | 5.98 |
MA(250) : | 6.2 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 52.6 |
D(3) : | 47.9 |
| RSI | RSI(14): 55.6 |
|||
| 52-week | High : | 10.27 | Low : | 4.05 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ QTRX ] has closed below upper band by 28.0%. Bollinger Bands are 64.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 8.15 - 8.2 | 8.2 - 8.24 |
| Low: | 7.29 - 7.34 | 7.34 - 7.38 |
| Close: | 7.33 - 7.41 | 7.41 - 7.48 |
Fri, 16 Jan 2026
The Truth About Quanterix Corp (QTRX): Tiny Biotech, Massive Hype – But Is It Worth Your Money? - AD HOC NEWS
Tue, 13 Jan 2026
Quanterix (QTRX) Price Target Increased by 11.54% to 7.40 - Nasdaq
Sat, 10 Jan 2026
Market Still Lacking Some Conviction On Quanterix Corporation (NASDAQ:QTRX) - simplywall.st
Sat, 10 Jan 2026
Market Still Lacking Some Conviction On Quanterix Corporation (NASDAQ:QTRX) - Sahm
Fri, 09 Jan 2026
$QTRX stock is up 27% today. Here's what we see in our data. - Quiver Quantitative
Fri, 09 Jan 2026
Analysts Offer Insights on Healthcare Companies: Quanterix (QTRX), Indivior (INDV) and GeneDx Holdings (WGS) - The Globe and Mail
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 47 (M) |
| Shares Float | 37 (M) |
| Held by Insiders | 5.9 (%) |
| Held by Institutions | 81.9 (%) |
| Shares Short | 3,430 (K) |
| Shares Short P.Month | 3,530 (K) |
| EPS | -2.34 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.73 |
| Profit Margin | -73.5 % |
| Operating Margin | -62.1 % |
| Return on Assets (ttm) | -11.3 % |
| Return on Equity (ttm) | -29.3 % |
| Qtrly Rev. Growth | 12.3 % |
| Gross Profit (p.s.) | 1.43 |
| Sales Per Share | 2.78 |
| EBITDA (p.s.) | -1.41 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -65 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | -3.17 |
| PEG Ratio | 0 |
| Price to Book value | 1.09 |
| Price to Sales | 2.65 |
| Price to Cash Flow | -5.32 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|